0001209191-19-014057.txt : 20190227 0001209191-19-014057.hdr.sgml : 20190227 20190227162233 ACCESSION NUMBER: 0001209191-19-014057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190225 FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ward Keith Wayne CENTRAL INDEX KEY: 0001662394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 19638020 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-25 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662394 Ward Keith Wayne 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Chief Development Officer Class A common stock 2019-02-25 4 C 0 15183 A 23803 D Class A common stock 2019-02-25 4 S 0 15183 91.00 D 8620 D Class A common stock 2019-02-26 4 C 0 25184 A 33804 D Class A common stock 2019-02-26 4 S 0 16817 91.00 D 16987 D Class A common stock 2019-02-26 4 S 0 8367 91.62 D 8620 D Employee Stock Option (right to buy) 11.00 2019-02-25 4 M 0 15183 0.00 D 2026-05-25 Class B common stock 15183 92967 D Class B common stock 2019-02-25 4 M 0 15183 11.00 A Class A common stock 15183 15183 D Class B common stock 2019-02-25 4 C 0 15183 D Class A common stock 15183 0 D Employee Stock Option (right to buy) 11.00 2019-02-26 4 M 0 16817 0.00 D 2026-05-25 Class B common stock 16817 76150 D Employee Stock Option (right to buy) 11.62 2019-02-26 4 M 0 8367 0.00 D 2023-06-15 Class B common stock 8367 0 D Class B common stock 2019-02-26 4 M 0 16817 11.00 A Class A common stock 16817 16817 D Class B common stock 2019-02-26 4 M 0 8367 11.62 A Class A common stock 8367 25184 D Class B common stock 2019-02-26 4 C 0 25184 D Class A common stock 25184 0 D The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016. The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013. /s/ Michael D. Wortley, attorney-in-fact 2019-02-27